Co-administration of cannabidiol and capsazepine reduces L-DOPA-induced dyskinesia in mice: Possible mechanism of action

Pharmacological manipulation of the endocannabinoid system represents a promising therapy to alleviate L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesia (LID) in Parkinson's disease (PD). Our aim was to verify whether cannabidiol (CBD), the major non-psychoactive constituent of Cannabis sativ...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Maurício dos-Santos-Pereira, Célia Aparecida da-Silva, Francisco Silveira Guimarães, Elaine Del-Bel
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Elsevier 2016-10-01
Цуврал:	Neurobiology of Disease
Нөхцлүүд:	Cannabinoid LID AIMs Neuroinflammation Anandamide CB1
Онлайн хандалт:	http://www.sciencedirect.com/science/article/pii/S096999611630153X
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!